Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation

European Journal of Pharmacology

Volumn 560, Issue 1, 2007, Pages 17-22

  Jawed, Sana ^a   Kim, Bora ^a   Ottenhof, Thomas ^a   Brown, Gregory M ^a   Werstiuk, Eva S ^a   Niles, Lennard P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antiproliferation; Apoptosis; Melatonin MT1 receptor mRNA and protein; MTT 3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide assay; Reverse transcription polymerase chain reaction (RT PCR); Western blot

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MELATONIN; MELATONIN 1 RECEPTOR; MESSENGER RNA; VALPROIC ACID; ANTICONVULSIVE AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BREAST TUMOR; DRUG COMBINATION; DRUG EFFECT; GENE EXPRESSION; METABOLISM; RAT; TUMOR CELL LINE; UPREGULATION;

ANIMALS; ANTICONVULSANTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG THERAPY, COMBINATION; GENE EXPRESSION; HUMANS; MELATONIN; RATS; RECEPTOR, MELATONIN, MT1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; VALPROIC ACID;

EID: 33847337369     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.022     Document Type: Article

References (27)

1. Armstrong K.J., and Niles L.P. Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells. NeuroReport 13 (2002) 473-475
2. Blaheta R.A., and Cinatl Jr. J. Anti-tumor mechanisms of valproate: a novel role for an old drug. Med. Res. Rev. 22 (2002) 492-511
3. Blask D.E., Dauchy R.T., and Sauer L.A. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 27 (2005) 179-188
4. Castro L.M.R., Gallant M., and Niles L.P. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J. Neurochem. 95 (2005) 1227-1236
5. Cinatl Jr. J., Cinatl J., Driever P.H., Kotchetkov R., Pouckova P., Kornhuber B., and Schwabe D. Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs 8 (1997) 958-963
6. Crocker C.E., and Niles L.P. Benzodiazepine-induced inhibition of human malignant melanoma (M-6) cell growth. Anticancer Res. 16 (1996) 1259-1263
7. del Rio B., Garcia Pedrero J.M., Martinez-Campa C., Zuazua P., Lazo P.S., and Ramos S. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J. Biol. Chem. 279 (2004) 38294-38302
8. Detich N., Bovenzi V., and Szyf M. Valproate induces replication-independent active DNA demethylation. J. Biol. Chem. 278 (2003) 27586-27592
9. Dubocovich M.L., and Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27 (2005) 101-110
10. Girgert R., Bartsch C., Hill S.M., Kreienberg R., and Hanf V. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. Neuro Endocrinol. Lett. 24 (2003) 440-444
11. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo Coco F., Nervi C., Pelicci P.G., and Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20 (2001) 6969-6978
12. Gurvich N., and Klein P.S. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Pharmacol. Ther. 96 (2002) 45-66
13. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., and Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 24 (2004) 6590-6599
14. Jung M. Inhibitors of histone deacetylase as new anticancer agents. Curr. Med. Chem. 8 (2001) 1505-1511
15. Kawagoe R., Kawagoe H., and Sano K. Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and-independent apoptotic signaling pathways. Leuk. Res. 26 (2002) 495-502
16. Leon-Blanco M.M., Guerrero J.M., Reiter R.J., Calvo J.R., and Pozo D. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J. Pineal Res. 35 (2003) 204-211
17. Li X.N., Shu Q., Su J.M., Perlaky L., Blaney S.M., and Lau C.C. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol. Cancer Ther. 4 (2005) 1912-1922
18. Mediavilla M.D., Cos S., and Sanchez-Barcelo E.J. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci. 65 (1999) 415-420
19. Niles L.P., Armstrong K.J., Rincon Castro L.M., Dao C.V., Sharma R., McMillan C.R., Doering L.C., and Kirkham D.L. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci. 5 (2004) 41
20. Olsen C.M., Meussen-Elholm E.T., Roste L.S., and Tauboll E. Antiepileptic drugs inhibit cell growth in the human breast cancer cell line MCF7. Mol. Cell. Endocrinol. 213 (2004) 173-179
21. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., and Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276 (2001) 36734-36741
22. Ram P.T., Yuan L., Dai J., Kiefer T., Klotz D.M., Spriggs L.L., and Hill S.M. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin. J. Pineal Res. 28 (2000) 210-218
23. Ram P.T., Dai J., Yuan L., Dong C., Kiefer T.L., Lai L., and Hill S.M. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett. 179 (2002) 141-150
24. Sainz R.M., Mayo J.C., Tan D.X., Leon J., Manchester L., and Reiter R.J. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 63 (2005) 29-43
25. Takai N., Kawamata N., Gui D., Said J.W., Miyakawa I., and Koeffler H.P. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis. Cancer 101 (2004) 2760-2770
26. Winczyk K., Pawlikowski M., Guerrero J.M., and Karasek M. Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer. Tumour Biol. 23 (2002) 298-302
27. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., and Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276 (2001) 31674-31683